Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 7, 2020
International multicenter examination of MOG antibody assays
Markus Reindl, Kathrin Schanda, Mark Woodhall, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
Neurology
|
December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study
Sara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.
Acta Neuropathologica Communications
|
September 5, 2019
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Fiona Tea, Joseph A Lopez, Sudarshini Ramanathan, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 15, 2025
Treatment response in children with relapsing MOG-antibody associated disease
Eva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Cell Reports. Medicine
|
March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Frontiers in Immunology
|
December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Plos Medicine
|
July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 22, 2025
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection
Avani Yeola, Samuel Houston, Anupriya Aggarwal, et al.
Ebiomedicine
|
November 16, 2024
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic
Anouschka Akerman, Christina Fichter, Vanessa Milogiannakis, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 7, 2020
International multicenter examination of MOG antibody assays
Markus Reindl, Kathrin Schanda, Mark Woodhall, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
Neurology
|
December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study
Sara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.
Acta Neuropathologica Communications
|
September 5, 2019
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Fiona Tea, Joseph A Lopez, Sudarshini Ramanathan, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 15, 2025
Treatment response in children with relapsing MOG-antibody associated disease
Eva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Cell Reports. Medicine
|
March 22, 2021
Long-term persistence of RBD<sup>+</sup> memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, et al.
Frontiers in Immunology
|
December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Plos Medicine
|
July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 22, 2025
COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection
Avani Yeola, Samuel Houston, Anupriya Aggarwal, et al.
Ebiomedicine
|
November 16, 2024
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic
Anouschka Akerman, Christina Fichter, Vanessa Milogiannakis, et al.
Page
of 13